Drug Shortage Report for APO-ABACAVIR-LAMIVUDINE

Last updated on 2019-07-29 History
Report ID 82102
Drug Identification Number 02399539
Brand name APO-ABACAVIR-LAMIVUDINE
Common or Proper name ABACAVIR-LAMIVUDINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ABACAVIR LAMIVUDINE
Strength(s) 600MG 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 BLS
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-04-17
Estimated end date 2019-08-09
Actual end date 2019-07-26
Shortage status Resolved
Updated date 2019-07-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-04-22 English Compare
v2 2019-04-22 French Compare
v3 2019-06-21 English Compare
v4 2019-06-21 French Compare
v5 2019-07-12 English Compare
v6 2019-07-12 French Compare
v7 2019-07-29 English Compare
v8 2019-07-29 French Compare

Showing 1 to 8 of 8